BioLineRx Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated August 18, 2026, serves as a report of a foreign private issuer. The filing announces the scheduling of the Annual Meeting of Shareholders for September 23, 2026, at 3:00 p.m. Israel time, to be held at the company's offices in Modi'in, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The primary update is the logistical announcement of the upcoming Annual General Meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or specific risk factors. It incorporates by reference the Notice of Annual General Meeting and Proxy Statement (Exhibit 99.1), which may contain additional details regarding matters to be voted upon.
Key Facts for Investors
- Meeting Date: September 23, 2026.
- Meeting Time: 3:00 p.m. Israel time.
- Location: BioLineRx Ltd. offices, Modi'in Technology Park, Israel.
- Documentation: Proxy materials and voting instruction forms for American Depositary Shareholders are attached as Exhibits 99.1, 99.2, and 99.3.
- Financial Data: None provided in this specific filing.